Omphalos Lifesciences

cropped-img_logo_omphalos.png
Menu

Press

Omphalos Signs MOU with FuriosaAI, KRIBB KPEC, Yonsei University, and Insilicox

We are excited to share that Omphalos Lifesciences Inc has joined a new industryโ€“academiaโ€“research consortium to accelerate ๐—”๐—œ-๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ฑ๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐˜‚๐˜€๐—ถ๐—ป๐—ด ๐—ป๐—ฒ๐˜…๐˜-๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฐ๐—ผ๐—บ๐—ฝ๐˜‚๐˜๐—ถ๐—ป๐—ด ๐—ถ๐—ป๐—ณ๐—ฟ๐—ฎ๐˜€๐˜๐—ฟ๐˜‚๐—ฐ๐˜๐˜‚๐—ฟ๐—ฒ. On March 13, Omphalos Korea signed an MOU with FuriosaAI, Korea Research Institute of Bioscience and Biotechnology (KRIBB) Korea Preclinical Evaluation Center (KPEC), Yonsei University College Read more…

By Omphalos Lifesciences, ago

Joint Research Agreement with Institut Pasteur Korea

We are pleased to announce a ๐‰๐จ๐ข๐ง๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก ๐€๐ ๐ซ๐ž๐ž๐ฆ๐ž๐ง๐ญ with Institut Pasteur Korea (IPK), a world-leading center for infectious disease research and a state-of-the-art scientific hub within the global Pasteur Network. IPK is internationally recognized for its advanced research infrastructure, including BSL-3 laboratory capabilities and high-throughput screening platforms that support Read more…

By Omphalos Lifesciences, ago

Omphalos Secures BARDA Support for Pathogen-Agnostic Antimicrobial Strategy Simulation

We are excited to share that Omphalos Lifesciences Inc has been selected to receive non-dilutive support from Biomedical Advanced Research and Development Authority (BARDA) through MATTERโ€™s Paratus digital health program! ๐Ÿ‘‰ Read the full article on MATTERโ€™s website This support enables us to advance our ๐ฉ๐ซ๐จ๐ ๐ซ๐š๐ฆ๐ฆ๐š๐›๐ฅ๐ž ๐ฏ๐ข๐ซ๐ญ๐ฎ๐š๐ฅ ๐œ๐ž๐ฅ๐ฅ ๐ญ๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ by Read more…

By Omphalos Lifesciences, ago

Omphalos Selected for BARDA-Backed Paratus Digital Health Accelerator

Weโ€™re excited to share that Omphalos Lifesciences Inc has been selected for MATTERโ€™s Paratus Digital Health Accelerator, part of the Biomedical Advanced Research and Development Authority (BARDA) Accelerator Network! ๐Ÿ‘‰ Read the full article on MATTERโ€™s website At Omphalos, we believe that programming biology is the key to building fast, Read more…

By Omphalos Lifesciences, ago